Navigation Links
Calixa Therapeutics to Make Multiple Presentations on CXA-101 and CXA-101/tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Date:9/11/2009

s of the presentations are as follows:

F1-1985: Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa

F1-1986: Activity Profile of CXA-101 and CXA-101/Tazobactam against Target Gram-Positive and Gram-Negative Pathogens

F1-1987: Activity of the New Cephalosporin CXA-101 against Carbapenem-Resistant Pseudomonas aeruginosa Isolates from a Spanish Multicenter Study

F1-1988: CXA-101 has High Activity against Clinical Isolates of Pseudomonas aeruginosa Including Ceftazidime-Resistant Isolates

F1-1989: Activity of CXA-101 against Pseudomonas aeruginosa beta-lactam Resistance Mechanisms: ampD, ampDh2, ampDh3, dacB (PBP4), and oprD Mutations

F1-1990: Activity of the New Cephalosporin CXA-101 against Biofilms of Relevant P. aeruginosa Phenotypes in Cystic Fibrosis Chronic Respiratory Infection: Mucoid and Hypermutable Strains

F1-1991: Activity of the New Cephalosporin CXA-101 against Biofilms of Relevant P. aeruginosa Phenotypes in Cystic Fibrosis Chronic Respiratory Infection: Mucoid and Hypermutable Strains

F1-1992: Activity of the Novel Cephalosporin CXA-101 Tested in Combination with Tazobactam against Cephalosporin-resistant Enterobacteriaceae, P. aeruginosa and B. fragilis

F1-1993: Activity of CXA-101 plus Tazobactam against ESBL-Producing Escherichia coli and Klebsiella pneumoniae

F1-1994: Chequerboard Titrations of Cephalosporin CXA-101 (FR264205) an
'/>"/>

SOURCE Calixa Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
2. Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ANDIEGO,Nov.24/PRNewswire-FirstCall/--OptimerPharm...atthe21stAnnualPiperJaffrayHealthCareConferenceatT...p.m.EasternTime. ,, (Logo: http://www.newscom.c...audiowebcastofthispresentationwillbeaccessibleonth...pharma.com .Replaysofthispresentationwillbeavaila...
(Date:11/23/2009)...INCINNATI,Nov.23/PRNewswire-FirstCall/--HealthWare...ail-orderpharmacy,todayannounceditsfinancialresult...yreportedquarterlyrevenueof$1,006,721,drivenbyheav...ssmarginsincreased13.0%year-over-yearto34.6%andthe...f$186,299forthethreemonthsendedSeptember30,2008. ,...
(Date:11/23/2009)...ATICK,Mass.,Nov.23/PRNewswire-FirstCall/--BostonSc...ipateinthePiperJaffrayHealthCareConference,Decembe...fficerandSamLeno,ExecutiveVicePresidentandChiefFin...nabouttheCompanyonTuesday,December1st,beginningata...iscussionwillbeavailabletoallinterestedpartiesatBo...
Breaking Medicine Technology:HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 3Satellite Healthcare Announces the Recipients of the 2009 Norman S Coplon Extramural Grants 57523 1Satellite Healthcare Announces the Recipients of the 2009 Norman S Coplon Extramural Grants 57523 2Satellite Healthcare Announces the Recipients of the 2009 Norman S Coplon Extramural Grants 57523 3Contraceptive Pill Named the Greatest Pharmacy Invention of the Last 150 Years in Chemist+Druggist Competition 57518 1Contraceptive Pill Named the Greatest Pharmacy Invention of the Last 150 Years in Chemist+Druggist Competition 57518 2Bolder BioTechnology Receives 241 2 Million NIH Grant to Continue Development of Long Acting EPO Analog for Chronic Kidney Disease 14125 1Bolder BioTechnology Receives 241 2 Million NIH Grant to Continue Development of Long Acting EPO Analog for Chronic Kidney Disease 14125 2Bolder BioTechnology Receives 241 2 Million NIH Grant to Continue Development of Long Acting EPO Analog for Chronic Kidney Disease 14125 3Bolder BioTechnology Receives 241 2 Million NIH Grant to Continue Development of Long Acting EPO Analog for Chronic Kidney Disease 14125 4
(Date:11/24/2009)...tementbeingPreparedbyLeadingLawFirm,NewTransferAge...-FirstCall/--AmericanScientificResourcesInc.(PinkS...currentcorporateupdate. ,, Sincefiling2007and20...diligentinaccomplishingadditionalgoals,whichareall...partofthisongoingprocess,2009thirdquarter(unaudite...
(Date:11/24/2009)...heezing, study finds , , TUESDAY, Nov. 2...raffic pollution and indoor endotoxin are at incre...xin -- a component of bacteria believed to trigger... , University of Cincinnati College of Medicine...arning sign of asthma and other lung conditions) i...
(Date:11/24/2009)...FirstCall/--Jamba,Inc.(Nasdaq: JMBA )announcedtoda...mbaJuice(TM)SmoothieandIcePopMaker,aJambaJuice-bra...eriencetochildrennationwide.CreatedtogetherwithThi...akerwillbeavailableataleadingtoyretailer,startingm...alU.S.retailersbeginningJanuary2010. ,, Targete...
(Date:11/24/2009)... embracing the latest tools of virtual communicati...e with patients. Through Facebook, Twitter, and ot...ormation about his Atlanta plastic surgery pract...s may have. , Atlanta, GA...n Atlanta is taking full advantage of new online ...
(Date:11/24/2009)...hes EyeCentral Remote Video Platform for the Secur... for Central Stations and Security Dealers. , ...r 24, 2009 -- NCL Security Launches EyeCentral Rem...nerate Recurring Monthly Revenue for Central Stati...urity systems has been and still is a great trend ...
Breaking Medicine News(10 mins):Health News:American Scientific Resources Inc. Issues Corporate Update 2Health News:American Scientific Resources Inc. Issues Corporate Update 3Health News:Traffic, Dust Linked to Asthma in Kids 2Health News:Jamba Juice and Think Wow Toys Bring the Smoothie Experience Home With Debut of Jamba Branded Toy Blender 2Health News:Jamba Juice and Think Wow Toys Bring the Smoothie Experience Home With Debut of Jamba Branded Toy Blender 3Health News:Atlanta Plastic Surgeon Using Social Media To Connect with Patients 2Health News:Atlanta Plastic Surgeon Using Social Media To Connect with Patients 3Health News:NCL Security Launches EyeCentral Video Platform for the Security Industry to Generate Recurring Monthly Revenue for Central Stations and Security Dealers 2
...ensive care, one expert says , , FRIDAY, J...r the phone, women struggling with postpartum depr... or mothers who have gone through the same thing, ...ers deal with their depression without the need fo...
...ribbin of Clarksburg, president and CEO of CentraS...alled as chairman of the board of the New Jersey H...organization. The chairman,s official installation..., the enormous problems faced by our facilities so...
...h January issue of Archives of Internal Medicine ...sure and outdoor temperature in a large sample of ...ise that, during periods of extreme temperatures, ... elderly". , The study, which monitored 8801 part...
...lth and the University of Colorado Denver have dis...rvival among patients with acute lung injury. Acut...ry infection and results in low oxygen levels in t...s each year, and killing 40 percent of them. , "Th...
...lth insurance market increasingly becomes consumer... seeking to serve people shopping for insurance wi...retail outlet scheduled for a grand opening Jan. 2...lueStore(SM) will open officially with a ribbon c...
...ental.com announces the availability of a speciali...er oral health care professionals. The site allows...clinical research, equipment specifications, conti...g to sift through consumer-targeted information," ...
Other Medicine News:Health News:Caring Counseling May Ease Postpartum Depression 2Health News:Caring Counseling May Ease Postpartum Depression 3Health News:Hospital Association Names New Chairman, Appoints Board Officers and New Members 2Health News:Seasonal variation in blood pressure 2Health News:Gene associated with reduced mortality from acute lung injury 2Health News:S.C. BlueCross to Open Its First Health Insurance Retail Store 2Health News:Includesdental.com Announces Search Engine for Dentists, Hygienists and Oral Health Industry 2
...Evaluation and Management guidelines in selecting ...nformation, it calculates the HCFA scores for each... of changing different parts of the exam. ZapCode ...ate an audit trail of your exam. It can print this...
MD Coder v6.0
MedCalc 3000
mobileMICROMEDE™
Medicine Products: